Identification and Characterization of Potential Impurities of Quetiapine Fumarate

被引:10
|
作者
Stolarczyk, Elzbieta U. [1 ]
Kaczmarek, Lukasz [1 ]
Eksanow, Kamil [1 ]
Kubiszewski, Marek [1 ]
Glice, Magdalena [1 ]
Kutner, Andrzej [1 ]
机构
[1] Pharmaceut Res Inst, PL-01793 Warsaw, Poland
关键词
quetiapine; impurities; identification; NMR; IR; MS; impurity profile; fragmentation pathway;
D O I
10.1080/10837450802409388
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Seven potential impurities, including by-products, starting materials and intermediates were identified in pharmaceutical Substance quetiapine fumarate and characterized by spectroscopic methods (MS, IR, NMR). Based on these methods the structures of the impurities were assigned or confirmed as: impurity 1: 2-(phenylthio)aniline; impurity II: phenyl N-[2-(phenylthio)phenyl]carbamate; impurity III: N,N'-bis[2-(phenylthio) phenyl]urea; impurity IV: N-[2-(phenylthio)phenyl]-1-piperazinecarboxamide hydrochloride; impurity V: N,N'-bis[(2-phenylthio)phenyl]-1,4-piperazinedicarboxamide; impurity VI: 11-(1-piperazinyl) dibenzo[b,f][1,4] thiazepine fumarate; impurity VII: 1,4-bis(dibenzo[b,f][1,4] thiazepin-11-yl)piperazine. Structural elucidation of compounds, proposed MS fragmentation pathway and possible ways of formation of the impurities are also discussed.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 50 条
  • [1] Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate
    Bharathi, Ch.
    Prabahar, K. J.
    Prasad, Ch. S.
    Rao, M. Srinivasa
    Trinadhachary, G. N.
    Handa, V. K.
    Dandala, R.
    Naidu, A.
    PHARMAZIE, 2008, 63 (01): : 14 - 19
  • [2] Trace-level determination of potential genotoxic impurities in quetiapine fumarate using LC-MS
    Kavitapu, DasameswaraRao
    Gopireddy, Ramana Reddy
    Maruthapillai, Arthanareeswari
    Murty, Jayanti Naga Sri Rama Chandra
    Katari, Naresh Kumar
    BIOMEDICAL CHROMATOGRAPHY, 2023, 37 (04)
  • [3] Identification and characterization of potential impurities of donepezil
    Reddy, KVSR
    Babu, JM
    Kumar, PA
    Chandrashekar, ERR
    Mathad, VT
    Eswaraiah, S
    Reddy, MS
    Vyas, K
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (05) : 1047 - 1058
  • [4] Identification and Characterization of Potential Impurities of Dronedarone Hydrochloride
    Mahender, M.
    Saravanan, M.
    Sridhar, Ch.
    Chandrashekar, E. R. R.
    Kumar, L. Jaydeep
    Jayashree, A.
    Bandichhor, Rakeshwar
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2014, 18 (01) : 157 - 162
  • [5] Identification and characterization of potential impurities of rabeprazole sodium
    Reddy, Ganta Madhusudhan
    Bhaskar, B. Vijaya
    Reddy, P. Pratap
    Sudhakar, P.
    Babu, J. Moses
    Vyas, K.
    Reddy, P. Ramachandra
    Mukkanti, K.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (04) : 1262 - 1269
  • [6] Identification and characterization of potential impurities of amlodipine maleate
    Sudhakar, P
    Nirmala, M
    Babu, JM
    Vyas, K
    Reddy, GM
    Bhaskar, BV
    Reddy, PP
    Mukkanti, K
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 40 (03) : 605 - 613
  • [7] Isolation, identification and characterization of potential impurities of anidulafungin
    Zhao, Lanning
    Wang, Qilong
    Bie, Yi
    Lu, Xiaoxia
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2017, 141 : 192 - 199
  • [8] Isolation, identification and characterization of potential impurities in cabazitaxel and their formation
    Wang, Yongyi
    Feng, Feng
    Chen, Lei
    Zhao, Hongtao
    Tian, Lianzhong
    MAGNETIC RESONANCE IN CHEMISTRY, 2014, 52 (12) : 783 - 788
  • [9] Structural identification and characterization of potential impurities of pantoprazole sodium
    Reddy, Ganta Madhusudhan
    Bhaskar, B. Vijaya
    Reddy, P. Pratap
    Ashok, S.
    Sudhakar, P.
    Babu, J. Moses
    Vyas, K.
    Mukkanti, K.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 45 (02) : 201 - 210
  • [10] Quetiapine Fumarate Seroquel® -: Antipsychotic
    不详
    DRUGS OF THE FUTURE, 2000, 25 (05) : 535 - 536